Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Briel

Showing results (201-210 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Epidemiology|May 8, 2020
Erratum to "A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses" [J Clin Epidemiol. 2019;113:159-67]Stefan Schandelmaier, Yaping Chang, Malgorzata M Bala, et al.
JAMA|May 23, 2013
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJörg D Leuppi, Philipp Schuetz, Roland Bingisser, et al.
European Journal of Endocrinology|April 10, 2015
Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trialPhilipp Schuetz, Jörg D Leuppi, Roland Bingisser, et al.
Journal of Clinical Epidemiology|March 6, 2018
Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological surveyLara A Kahale, Batoul Diab, Romina Brignardello-Petersen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 12, 2020
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analysesStefan Schandelmaier, Matthias Briel, Ravi Varadhan, et al.
Journal of Clinical Epidemiology|May 23, 2017
GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidenceGordon H Guyatt, Shanil Ebrahim, Pablo Alonso-Coello, et al.
Evidence-Based Child Health : a Cochrane Review Journal|July 24, 2013
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
AIDS (London, England)|October 13, 2023
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysisPhilipp Schuetz, Matthias Briel, Mirjam Christ-Crain, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
Pageof 29

Showing results (201-210 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Epidemiology|May 8, 2020
Erratum to "A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses" [J Clin Epidemiol. 2019;113:159-67]Stefan Schandelmaier, Yaping Chang, Malgorzata M Bala, et al.
JAMA|May 23, 2013
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJörg D Leuppi, Philipp Schuetz, Roland Bingisser, et al.
European Journal of Endocrinology|April 10, 2015
Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trialPhilipp Schuetz, Jörg D Leuppi, Roland Bingisser, et al.
Journal of Clinical Epidemiology|March 6, 2018
Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological surveyLara A Kahale, Batoul Diab, Romina Brignardello-Petersen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 12, 2020
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analysesStefan Schandelmaier, Matthias Briel, Ravi Varadhan, et al.
Journal of Clinical Epidemiology|May 23, 2017
GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidenceGordon H Guyatt, Shanil Ebrahim, Pablo Alonso-Coello, et al.
Evidence-Based Child Health : a Cochrane Review Journal|July 24, 2013
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
AIDS (London, England)|October 13, 2023
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysisPhilipp Schuetz, Matthias Briel, Mirjam Christ-Crain, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
Pageof 29